AIDS News and Research

RSS

Researchers identify how sooty mangabeys survive SIV infection

Sooty mangabeys, a type of African monkey, have intrigued scientists for years because they can survive infection by SIV, a relative of HIV, and not succumb to AIDS.

27 Jun 2011

Anticholinergic medications linked to risk of cognitive impairment, death in older population

A large, long-term study confirms that medications with anticholinergic activity, which include many drugs frequently taken by older adults, cause cognitive impairment. The research is also the first to identify a possible link between these drugs - which include over-the-counter and prescription sleep aids and incontinence treatments - and risk of death.

27 Jun 2011

Michelle Obama's message of leadership for 'HIV-free future'

U.S. Global AIDS Coordinator Ambassador Eric Goosby writes about First Lady Michelle Obama's trip to Africa and her focus on "youth leadership, education, health and wellness," including HIV/AIDS, in this Office of National AIDS Policy blog post.

24 Jun 2011

Michelle Obama visits HIV/AIDS clinic in Botswana

"Michelle Obama on Friday began the second leg of her weeklong visit to Africa by wielding a brush to help paint a mural" at the Botswana-Baylor Children's Clinical Center of Excellence in the capital city of Gaborone, the Associated Press reports. The clinic serves 4,000 children and their families who have been affected by HIV/AIDS, according to the news service (Superville, 6/24).

24 Jun 2011

Department of Defense awards Impel Phase II SBIR grant for blood-brain barrier bypass technology

Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."

24 Jun 2011

FDA approves second anti-HIV drug from Rutgers-Janssen collaboration

Two decades after Rutgers scientists began working with Paul Janssen, a legendary drug developer and founder of Johnson & Johnson subsidiary Janssen Pharmaceutica, to create new and potent drugs to fight AIDS, the FDA has approved the second anti-HIV drug that came from this collaboration.

24 Jun 2011

Evolutionary-management strategies to limit spread of drug-resistant diseases

In the war between drugs and drug-resistant diseases, is the current strategy for medicating patients giving many drug-resistant diseases a big competitive advantage?, asks a research paper that will be published in the Proceedings of the National Academy of Sciences.

24 Jun 2011

Project to explore aspects of music for cochlear implant users

Researchers from the University of Southampton are investigating how to help deaf people, who have received a cochlear implant, to get more enjoyment from music.

24 Jun 2011

Global Fund signs onto International Aid Transparency Initiative

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced Thursday that "it has become a signatory of the International Aid Transparency Initiative, which "means that grant information currently on the Global Fund website will be aligned to an internationally agreed set of standards" and "financial and grant activity data and documentation will be accessible to a broader audience and will be comparable to information provided by other donors," according to a Global Fund press release.

24 Jun 2011

GeoVax opens third clinical trial site for testing HIV/AIDS vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a third site for testing the therapeutic potential of its HIV/AIDS vaccine.

24 Jun 2011

Michelle Obama talks about AIDS, women's rights on Africa trip

First Lady Michelle Obama, who is on a trip to Africa, "urged young Africans on Wednesday to fight for women's rights and battle the stigma of AIDS, using her husband's 'yes, we can' campaign slogan to motivate youth across the continent," Reuters reports.

23 Jun 2011

Studies: Health law aids employer health coverage

Research released yesterday by the Robert Wood Johnson Foundation and the Urban Institute offered a very different view of the impact the health law would have on employer-based health coverage than a controversial survey released last week by McKinsey and Co.

23 Jun 2011

Eradicating malaria is a 'realistic possibility'

Eliminating malaria in endemic countries is a "realistic possibility if those countries keep expanding malaria prevention and treatment at the pace set in recent years," Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, writes on the Bill & Melinda Gates Foundation's blog.

23 Jun 2011

State roundup: Okla. caps 'non-economic damages' in lawsuits

With Republicans in control of the Oklahoma governorship and the Legislature for the first time ever, they swiftly passed a series of changes to the civil justice system. Lawmakers put a cap of $350,000 on the amount of money that plaintiffs can recoup for so-called "non-economic damages," such as the pain and suffering caused by medical malpractice, faulty products or other forms of professional negligence.

23 Jun 2011

Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection

Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).

22 Jun 2011

First Edition: June 22, 2011

Today's headlines include an exclusive AP report detailing a "twist" in the health law that would allow millions of middle class Americans -- mainly early retirees -- access to Medicaid.

22 Jun 2011

Ghana's vice president discusses country's efforts to fight HIV/AIDS

John Dramani Mahama, vice president of the Republic of Ghana, recently spoke with NPR's "Tell Me More" about how Ghana has made significant gains against HIV/AIDS, bringing the prevalence rate down to 1.5 percent from nearly 4 percent.

22 Jun 2011

'Steadfast focus' needed in fight against HIV/AIDS

Recapping the 30-year history of HIV/AIDS from an USAID perspective, Administrator Rajiv Shah writes in this "Impact blog" post, "Our work is far from done. We have a shared responsibility as a global partner to save lives by focusing on smart investments. The generosity of the American people has made sustained progress against this deadly disease possible. Closing the chapter on HIV/AIDS will require a steadfast focus on remaining gaps and challenges as we chart the way forward".

22 Jun 2011

Scientists apply math model to HIV to discover targets for vaccines or drugs

Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be a prime target for AIDS vaccines or drugs," the Wall Street Journal reports.

22 Jun 2011

DIA recognizes CAPRISA team for outstanding achievement in HIV prevention

Today the CAPRISA 004 study leadership team is being awarded the inaugural Drug Information Association (DIA) President's Award for Outstanding Achievement in World Health.

21 Jun 2011